ADP receptor inhibitors, such as thienopyridine, ticlopidine, and clopidogrel, are widely used in the treatment of cardiac and cerebrovascular diseases [29] relevant to atherosclerosis and atherothrombosis. Here, P2RY1 is linked to atherosclerosis.